Recent advances in the neurochemical pathology of Alzheimer's disease. Studies of neuropeptides, cholinergic function and Alzheimer's disease- associated protein

Charles Nemeroff, G. Bissette, T. A. Slotkin, F. J. Seidler, B. E. Miller, H. Ghanbari

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Our findings from three postmortem tissue studies in Alzheimer's disease (AD) are presented. We investigated (1) alterations in somatostatin (SRIF) and corticotropin-releasing factor (CRF) in AD; (2) regulatory changes in presynaptic cholinergic function in AD; and (3) use of Alzheimer's disease- associated protein (ADAP) as a diagnostic test for AD in postmortem tissue. Taken together, these findings reveal marked reductions in SRIF and CRF concentrations in many cerebrocortical areas in AD, a marked up-regulation of cholinergic neuronal activity in surviving cholinergic neurons in AD, and excellent specificity and sensitivity for the use of the ADAP assay as a diagnostic test for AD in postmortem tissue.

Original languageEnglish
Pages (from-to)193-196
Number of pages4
JournalAnnals of the New York Academy of Sciences
Volume640
StatePublished - Dec 1 1991
Externally publishedYes

Fingerprint

Pathology
Neuropeptides
Cholinergic Agents
Alzheimer Disease
Proteins
Corticotropin-Releasing Hormone
Routine Diagnostic Tests
Tissue
Cholinergic Neurons
Protein
Alzheimer's Disease
Somatostatin
Up-Regulation
Neurons
Assays
Sensitivity and Specificity

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Recent advances in the neurochemical pathology of Alzheimer's disease. Studies of neuropeptides, cholinergic function and Alzheimer's disease- associated protein. / Nemeroff, Charles; Bissette, G.; Slotkin, T. A.; Seidler, F. J.; Miller, B. E.; Ghanbari, H.

In: Annals of the New York Academy of Sciences, Vol. 640, 01.12.1991, p. 193-196.

Research output: Contribution to journalArticle

@article{7e18c54a5e634cb4a559b65b76e6c9da,
title = "Recent advances in the neurochemical pathology of Alzheimer's disease. Studies of neuropeptides, cholinergic function and Alzheimer's disease- associated protein",
abstract = "Our findings from three postmortem tissue studies in Alzheimer's disease (AD) are presented. We investigated (1) alterations in somatostatin (SRIF) and corticotropin-releasing factor (CRF) in AD; (2) regulatory changes in presynaptic cholinergic function in AD; and (3) use of Alzheimer's disease- associated protein (ADAP) as a diagnostic test for AD in postmortem tissue. Taken together, these findings reveal marked reductions in SRIF and CRF concentrations in many cerebrocortical areas in AD, a marked up-regulation of cholinergic neuronal activity in surviving cholinergic neurons in AD, and excellent specificity and sensitivity for the use of the ADAP assay as a diagnostic test for AD in postmortem tissue.",
author = "Charles Nemeroff and G. Bissette and Slotkin, {T. A.} and Seidler, {F. J.} and Miller, {B. E.} and H. Ghanbari",
year = "1991",
month = "12",
day = "1",
language = "English",
volume = "640",
pages = "193--196",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Recent advances in the neurochemical pathology of Alzheimer's disease. Studies of neuropeptides, cholinergic function and Alzheimer's disease- associated protein

AU - Nemeroff, Charles

AU - Bissette, G.

AU - Slotkin, T. A.

AU - Seidler, F. J.

AU - Miller, B. E.

AU - Ghanbari, H.

PY - 1991/12/1

Y1 - 1991/12/1

N2 - Our findings from three postmortem tissue studies in Alzheimer's disease (AD) are presented. We investigated (1) alterations in somatostatin (SRIF) and corticotropin-releasing factor (CRF) in AD; (2) regulatory changes in presynaptic cholinergic function in AD; and (3) use of Alzheimer's disease- associated protein (ADAP) as a diagnostic test for AD in postmortem tissue. Taken together, these findings reveal marked reductions in SRIF and CRF concentrations in many cerebrocortical areas in AD, a marked up-regulation of cholinergic neuronal activity in surviving cholinergic neurons in AD, and excellent specificity and sensitivity for the use of the ADAP assay as a diagnostic test for AD in postmortem tissue.

AB - Our findings from three postmortem tissue studies in Alzheimer's disease (AD) are presented. We investigated (1) alterations in somatostatin (SRIF) and corticotropin-releasing factor (CRF) in AD; (2) regulatory changes in presynaptic cholinergic function in AD; and (3) use of Alzheimer's disease- associated protein (ADAP) as a diagnostic test for AD in postmortem tissue. Taken together, these findings reveal marked reductions in SRIF and CRF concentrations in many cerebrocortical areas in AD, a marked up-regulation of cholinergic neuronal activity in surviving cholinergic neurons in AD, and excellent specificity and sensitivity for the use of the ADAP assay as a diagnostic test for AD in postmortem tissue.

UR - http://www.scopus.com/inward/record.url?scp=0026377022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026377022&partnerID=8YFLogxK

M3 - Article

C2 - 1685644

AN - SCOPUS:0026377022

VL - 640

SP - 193

EP - 196

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -